Trials / Completed
CompletedNCT00405457
Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy, safety and tolerability of a combination of Optive® Artificial Tears with Restasis®.The primary hypothesis is that the Ocular Surface Disease Index (OSDI) score and symptoms will be the same or lower than baseline after treatment in these patients. The patients will tolerate the combination of Restasis® and Optive® with a low incidence of clinical adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Restasis, Optive Tears | Restasis and Optive Tears use twice daily more frequently if needed |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2006-11-30
- Last updated
- 2010-02-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00405457. Inclusion in this directory is not an endorsement.